PARTNERS trial begins enrolling patients in DRC to test treatments for Bundibugyo virus disease
Summary
The PARTNERS clinical trial has begun enrolling patients in the Democratic Republic of the Congo to evaluate potential treatments for Bundibugyo virus disease (BVD), a form of Ebola. The trial will test two antiviral therapies — a monoclonal antibody (MBP134) and remdesivir — both individually and in combination, to determine if they can improve survival rates. This marks a major international effort to find the first effective treatments specifically for BVD.
Source
Key quotes
· 3 pulledThe PARTNERS clinical trial has opened enrolment today for patients in the Democratic Republic of the Congo.
The trial will assess whether two antiviral therapies – a monoclonal antibody (MBP134) and remdesivir – can improve survival among people diagnosed with BVD.
It will also evaluate whether combining the two antivirals provides additional benefits.
You might also wanna read
Bundibugyo virus disease outbreak: 695 confirmed cases across DRC and Uganda
The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo and Uganda continues to evolve, with 676 confirmed cases
ECDC assessment of modelling evidence on Bundibugyo virus spread in DRC and Uganda Ebola outbreak
This ECDC assessment provides an overview and critical appraisal of modelling evidence regarding the scale and potential spread of Bundibugy
CDC Model Projects Bundibugyo Virus Outbreak Growth in DRC Over Three Months
This report from the CDC describes using a transmission model to project the growth of the Bundibugyo virus disease (BVD) outbreak in the De
OMS anuncia ensaio clínico de dois tratamentos contra ebola na República Democrática do Congo
A Organização Mundial da Saúde (OMS) anunciou que lançará um ensaio clínico sobre dois tratamentos contra o ebola na próxima semana na Repúb
Epidemiological data and scripts for the 2026 Bundibugyo Ebola outbreak (BDBV)
This repository contains data and scripts for the epidemiological analysis of the 2026 Bundibugyo Ebolavirus (BDBV) outbreak, led by the Ins
Ebola outbreak (Bundibugyo virus) in DRC and Uganda reaches 381 confirmed cases, WHO declares public health emergency
An Ebola disease outbreak caused by the Bundibugyo virus continues to affect the Democratic Republic of the Congo (DRC) and Uganda as of Jun

Comments
Sign in to join the conversation.
No comments yet. Be the first.